tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
Advertisement

Monte Rosa Therapeutics (GLUE) Revenue

Compare
344 Followers

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had a revenue of 12.77M in the quarter ending Sep 30, 2025, with -44.95%. This bring the company's revenue in the last twelve months to 181.54M, Decreased 2.00%. In the fiscal year ending Dec 31, 2024, Monte Rosa Therapeutics had annual revenue of 75.62M with Infinity% growth.
Revenue (ttm)
181.54M
Revenue Growth
1112.27%
P/S Ratio
13.77
Revenue/Employee
$532,549
Employees
142
Market Cap
$1.04B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
75.62M-7,562,200,000.00%
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis